Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

NeuroPhage Pharmaceuticals (Cambridge, MA) a development-stage biopharmaceutical company focused on small molecules for protein aggregation diseases such as Alzheimer’ and Parkinson’s disease, closed a $9M Series B financing, bringing the total round to $21.4M. Participants include Merieux Developpement and Shire.

Stemgent (Cambridge, MA) a commercial-stage biopharmaceutical company focused on stem cell reagents and tools for stem cell researchers, closed a $6.3M Series C financing. Participants include HealthCare Ventures and Morganthaler Partners.

Mevion Medical Systems (Littleton, MA) a commercial-stage medical device company focused on proton beam radiotherapy device for cancer, closed a $45M Series G financing. Participants include ProQuest Investment, Caxton Heath Life Sciences, Venrock and CHL Medical Partners.

ImmuneXcite (Watertown, MA) a development-stage biopharmaceutical company focused on a therapeutic platform for the development of monoclonal antibodies and vaccines for cancer and infectious diseases, closed a $2.4M Series A financing. Participants include Boston Harbor Angels.

MC10 (Cambridge, MA) a development-stage medical device company focused on flexible, portable electronic medical devices for diagnosing, monitoring body functions and performance via parameters such as the heart (ECG), brain (EEG), muscle (EMG), body temp and hydration, closed a $2M Series B financing, bringing the total round to $17.1M. Participants include Aberdare Ventures.

ImmuneXcite (Watertown, MA) a development-stage biopharmaceutical company focused on a therapeutic platform for the development of monoclonal antibodies and vaccines for cancer and infectious diseases, closed a $2.4M Series A financing. Participants include Boston Harbor Angels.

Warp Drive Bio (Cambridge, MA) a development-stage biopharma company focused on a proprietary genomic search engine to identify and develop natural product drug candidates in microbes to target previously undruggable targests, closed a $75M Series A financing. Participants include Third Rock Ventures, Greylock Partners and Sanofi.

RaNA Therapeutics (Cambridge, MA) a development-stage biopharmaceutical company focused on platform that allows selective gene activation and therapeutic factor expression by targeting long, noncoding RNA, closed a $20.7M Series A financing. Participants include Monsanto, SR One and Atlas Venture.

Physicians Interactive Holdings (Marlborough, MA) a commercial-stage medical-IT company focused on healthcare information, medication samples and mobile decision support tools for medical professionals, closed a $8.5M Series A financing. Participants include Merck Global Health Innovation Fund.

Syndexa Pharmaceuticals (Watertown, MA) a clinical-stage biopharmaceutical company focused on enzyme inhibitors for Alzheimer’s disease and inflammatory diseases, closed a $8.5M Series B financing. Participants include MP Healthcare Venture Management.

MedVentive (Waltham, MA) a commercial-stage electronic medical data company focused on clinical integration, population management and financial risk management, closed a $12M Series D financing. Participants include National Healthcare Services, CHV Capital, Core Capital Partners, Excel Venture Management, HLM Venture Partners and Long River Ventures.

Firefly BioWorks (Cambridge, MA) a development-stage biotechnologycompany focused on an open platform multiplexed biological assay standardization for the quantification of biological function, closed a $2M Series A financing. Participants were not identified.

OvaScience (Boston, MA) a development-stage biotechnology company focused on mitochondria rejuvenation to improve fertility, closed a Series A financing. Participants include Bessemer Venture Partners and Longwood Founders Fund.

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...